These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 7681524

  • 1. Genotoxic effects of selected peroxisome proliferators.
    Reisenbichler H, Eckl PM.
    Mutat Res; 1993 Apr; 286(2):135-44. PubMed ID: 7681524
    [Abstract] [Full Text] [Related]

  • 2. Induction of sister chromatid exchange and micronuclei in primary cultures of rat and human hepatocytes by the peroxisome proliferator, Wy-14,643.
    Hwang JJ, Hsia MT, Jirtle RL.
    Mutat Res; 1993 Apr; 286(2):123-33. PubMed ID: 7681523
    [Abstract] [Full Text] [Related]

  • 3. Induction of peroxisomal acyl CoA oxidase activity and lipid peroxidation in primary rat hepatocyte cultures.
    Tomaszewski KE, Heindel SW, Jenkins WL, Melnick RL.
    Toxicology; 1990 Dec 17; 65(1-2):49-60. PubMed ID: 2274969
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.
    Reddy JK, Reddy MK, Usman MI, Lalwani ND, Rao MS.
    Environ Health Perspect; 1986 Mar 17; 65():317-27. PubMed ID: 3709457
    [Abstract] [Full Text] [Related]

  • 8. Hypolipidaemic drugs are activated to acyl-CoA esters in isolated rat hepatocytes. Detection of drug activation by human liver homogenates and by human platelets.
    Bronfman M, Morales MN, Amigo L, Orellana A, Nuñez L, Cárdenas L, Hidalgo PC.
    Biochem J; 1992 May 15; 284 ( Pt 1)(Pt 1):289-95. PubMed ID: 1599408
    [Abstract] [Full Text] [Related]

  • 9. Detection of a nafenopin-binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds.
    Lalwani ND, Fahl WE, Reddy JK.
    Biochem Biophys Res Commun; 1983 Oct 31; 116(2):388-93. PubMed ID: 6651818
    [Abstract] [Full Text] [Related]

  • 10. Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes.
    Eckl PM, Ortner A, Esterbauer H.
    Mutat Res; 1993 Dec 31; 290(2):183-92. PubMed ID: 7694109
    [Abstract] [Full Text] [Related]

  • 11. Rodent hepatocarcinogenic peroxisome proliferators induce proliferation of rat hepatocytes in primary mixed cultures with rat liver epithelial cells.
    Perrone CE, Williams GM.
    Cancer Lett; 1998 Jan 16; 123(1):27-33. PubMed ID: 9461014
    [Abstract] [Full Text] [Related]

  • 12. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation.
    Rao MS, Subbarao V.
    Fundam Appl Toxicol; 1997 Jan 16; 35(1):78-83. PubMed ID: 9024675
    [Abstract] [Full Text] [Related]

  • 13. Induction of rat liver DNA alterations by chronic administration of peroxisome proliferators as detected by 32P-postlabeling.
    Randerath E, Randerath K, Reddy R, Danna TF, Rao MS, Reddy JK.
    Mutat Res; 1991 Mar 16; 247(1):65-76. PubMed ID: 2002806
    [Abstract] [Full Text] [Related]

  • 14. Assessment of peroxisome proliferation and liver growth-stimulating potential by nondirectly genotoxic compounds in cultured hepatocytes.
    Bieri F, Stäubli W, Kelly S, Waechter F, Bentley P.
    Mol Toxicol; 1991 Mar 16; 1(4):439-44. PubMed ID: 3151502
    [Abstract] [Full Text] [Related]

  • 15. Reduction of the concentrations of prostaglandins E2 and F2alpha, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate.
    Leung LK, Glauert HP.
    Toxicol Lett; 1996 Jun 16; 85(3):143-9. PubMed ID: 8644126
    [Abstract] [Full Text] [Related]

  • 16. Calcium as a permissive factor but not an initiation factor in DNA synthesis induction in cultured rat hepatocytes by the peroxisome proliferator ciprofibrate.
    Bennett AM, Williams GM.
    Biochem Pharmacol; 1993 Dec 14; 46(12):2219-27. PubMed ID: 8274155
    [Abstract] [Full Text] [Related]

  • 17. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
    Perrone CE, Shao L, Williams GM.
    Toxicol Appl Pharmacol; 1998 Jun 14; 150(2):277-86. PubMed ID: 9653058
    [Abstract] [Full Text] [Related]

  • 18. Effects of the peroxisome proliferator ciprofibrate and prostaglandin F2 alpha combination treatment on second messengers in cultured rat hepatocytes.
    Hong JT, Yun YP.
    Arch Pharm Res; 1998 Apr 14; 21(2):120-7. PubMed ID: 9875418
    [Abstract] [Full Text] [Related]

  • 19. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.
    Graham MJ, Winham MA, Old SL, Gray TJ.
    Xenobiotica; 1996 Jul 14; 26(7):695-707. PubMed ID: 8819300
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis.
    Yeldandi AV, Milano M, Subbarao V, Reddy JK, Rao MS.
    Cancer Lett; 1989 Sep 15; 47(1-2):21-7. PubMed ID: 2636030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.